• Fr
  • En
  • Early Access Programs
    • About Early Access in France
    • Our Early Access Services
  • Exploitant Status
    • About Exploitant status
    • Our Exploitant Services
  • About us
    • About us
    • Our commitments
      • Quality Policy
      • Data Privacy Policy
  • Ressources
  • Glossary
  • Contact us
    • Send us a message
    • Office locator
  • Early Access Programs
    • About Early Access in France
    • Our Early Access Services
  • Exploitant Status
    • About Exploitant status
    • Our Exploitant Services
  • About us
    • About us
    • Our commitments
      • Quality Policy
      • Data Privacy Policy
  • Ressources
  • Glossary
  • Contact us
    • Send us a message
    • Office locator
Pharmablue / Exploitant Status

Categories

  • All
  • Blog Posts
  • Papers
  • Webinars
Papers

Papers

 - 

6 March 2025

Exploitant services for MAA product

Download our latest Case Study: Exploitant services for MAA product You will learn more about: ▪ Exploitant status in France ▪ Exploitant services ▪ Pharmablue our Exploitant establishement

Blog Posts

Blog Posts

 - 

6 March 2025

Everything to know about exploitant status in France

About the "Exploitant" status French regulatory authorities require having an « Exploitant » authorized and established in France to manage an early access program in France or a Marketing authorization. At the European level, there are three separate positions: The…

Contact our experts today

Composed of proven experts from the pharmaceutical industry, our team is ready to answer your needs and support you to bring your innovative therapies to patients with unmet medical needs

Send a request

About us

Welcome to PharmaBlue a PharmaLex company. PharmaBlue is a partner “Exploitant” of innovative Pharma Companies for the marketing in France of their medicinal products which have been granted an Early access authorization (EAP previously ATU) or a Marketing Authorization (MA)

 

PharmaBlue holds an “Etablissement Pharmaceutique Exploitant” license from ANSM and can take over the organisation and supervision of the distribution in France of pharmaceuticals products.

Links

  • News & Resources
  • Terms of use
  • Data Privacy Policy
  • Patient information notice
  • Healthcare Profesionals information notice

Get in touch